Glaxo Acetaminophen Efficacy Studies Fill FDA's 1,000-MG Dose Data Gaps
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline generated clinical data supporting the greater pain-relief efficacy of 1,000 mg of acetaminophen over 500-mg and 650-mg doses, urging FDA to maintain OTC status for the high dose.
You may also be interested in...
In Brief
Valeant buys Brazilian nutrition firm Probiotica; Nutraceutical International keeps up acquisitions; Claritin weighs on Merck consumer in Q4; J&J acetaminophen study backs Glaxo; more news In Brief.
McNeil Lowers Recommended Maximum Dose For Extra Strength Tylenol
McNeil Consumer Healthcare lowers the maximum daily dose indicated on labels of Extra Strength Tylenol, the first in a series of dosing changes for the firm’s acetaminophen-containing products.
McNeil Lowers Recommended Maximum Dose For Extra Strength Tylenol
McNeil Consumer Healthcare lowers the maximum daily dose indicated on labels of Extra Strength Tylenol, the first in a series of dosing changes for the firm’s acetaminophen-containing products.